Strides Potassium Chloride Tablets Recall: Failed Dissolution Risk
Strides Pharma Inc. recalls potassium chloride extended-release tablets due to failed dissolution specifications. This may affect medication effectiveness. Check NDC 64380-860-06 or 7240675A.
Lower-risk recall
Failed Dissolution Specifications
Contact the company
What happened, in plain English
Strides Pharma Inc. is recalling potassium chloride extended-release tablets that may not dissolve properly as intended. This could lead to incorrect medication dosing if taken as prescribed. Read more at govinfonow.com/recall/36826-strides-potassium-chloride-tablets-recall-failed-dissolution-risk.
Source Summary by GovInfoNow · govinfonow.com/recall/36826-strides-potassium-chloride-tablets-recall-failed-dissolution-risk · Updated October 4, 2026 · FDA enforcement record: FDA #D-0001-2021
Cite this page
“Strides Potassium Chloride Tablets Recall: Failed Dissolution Risk.” GovInfoNow, updated October 4, 2026. https://govinfonow.com/recall/36826-strides-potassium-chloride-tablets-recall-failed-dissolution-risk. Based on FDA recall #D-0001-2021 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0001-2021%22&limit=1).
Why it’s dangerous
The tablets may not dissolve correctly in the stomach, leading to inconsistent potassium levels in the bloodstream. This could cause incorrect dosing if taken as directed, especially for patients with kidney conditions or those on potassium-restricted diets.
Who’s affected
Prescription patients who received these specific potassium chloride tablets from Strides Pharma Inc. in the US. Those with kidney issues or on potassium-restricted diets are at higher risk due to potential dosing errors.
How to tell if you have this one
Check for NDC code 64380-860-06 or 7240675A on the packaging. These tablets were manufactured in Bengaluru, India and distributed by Strides Pharma Inc. in the US. They expire December 31, 2021.
- Brand
Strides- Category
Drug
What to do — step by step
Check Product Details
Look for NDC codes 64380-860-06 or 7240675A on the packaging to confirm if you have the recalled tablets.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 17 months after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0001-2021 (August 24, 2020) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0001-2021 to see it in context.
- Plain-language summary written by qwen3:4b on October 4, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.